Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for LQDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 284.18M
March 31, 2026 222.79M
December 31, 2025 190.68M
September 30, 2025 157.50M
June 30, 2025 173.42M
March 31, 2025 169.76M
December 31, 2024 176.48M
September 30, 2024 204.37M
June 30, 2024 133.09M
March 31, 2024 157.86M
December 31, 2023 83.68M
September 30, 2023 76.22M
June 30, 2023 88.20M
March 31, 2023 94.41M
December 31, 2022 93.28M
September 30, 2022 98.32M
June 30, 2022 103.84M
March 31, 2022 57.79M
Date Value
December 31, 2021 57.49M
September 30, 2021 64.05M
June 30, 2021 67.89M
March 31, 2021 53.64M
December 31, 2020 65.32M
September 30, 2020 79.55M
June 30, 2020 23.59M
March 31, 2020 40.13M
December 31, 2019 55.80M
September 30, 2019 39.30M
June 30, 2019 52.12M
March 31, 2019 60.81M
December 31, 2018 39.54M
September 30, 2018 47.52M
June 30, 2018 9.232M
March 31, 2018 17.59M
December 31, 2017 3.419M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Indivior Pharmaceuticals, Inc. 222.00M
Harmony Biosciences Holdings, Inc. 667.79M
Johnson & Johnson 20.76B
United Therapeutics Corp. 2.662B
Amneal Pharmaceuticals, Inc. 136.28M